JP2011506447A5 - - Google Patents

Download PDF

Info

Publication number
JP2011506447A5
JP2011506447A5 JP2010537971A JP2010537971A JP2011506447A5 JP 2011506447 A5 JP2011506447 A5 JP 2011506447A5 JP 2010537971 A JP2010537971 A JP 2010537971A JP 2010537971 A JP2010537971 A JP 2010537971A JP 2011506447 A5 JP2011506447 A5 JP 2011506447A5
Authority
JP
Japan
Prior art keywords
connexin
agent
polynucleotide
pharmaceutical composition
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010537971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011506447A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/013656 external-priority patent/WO2009075882A2/en
Publication of JP2011506447A publication Critical patent/JP2011506447A/ja
Publication of JP2011506447A5 publication Critical patent/JP2011506447A5/ja
Withdrawn legal-status Critical Current

Links

JP2010537971A 2007-12-11 2008-12-11 損傷した創傷治癒組成物および治療 Withdrawn JP2011506447A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US726207P 2007-12-11 2007-12-11
PCT/US2008/013656 WO2009075882A2 (en) 2007-12-11 2008-12-11 Impaired wound healing compositions and treatments

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014097425A Division JP2014144976A (ja) 2007-12-11 2014-05-09 損傷した創傷治癒組成物および治療

Publications (2)

Publication Number Publication Date
JP2011506447A JP2011506447A (ja) 2011-03-03
JP2011506447A5 true JP2011506447A5 (https=) 2013-01-31

Family

ID=40626592

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010537971A Withdrawn JP2011506447A (ja) 2007-12-11 2008-12-11 損傷した創傷治癒組成物および治療
JP2014097425A Withdrawn JP2014144976A (ja) 2007-12-11 2014-05-09 損傷した創傷治癒組成物および治療
JP2016082856A Pending JP2016135799A (ja) 2007-12-11 2016-04-18 損傷した創傷治癒組成物および治療

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014097425A Withdrawn JP2014144976A (ja) 2007-12-11 2014-05-09 損傷した創傷治癒組成物および治療
JP2016082856A Pending JP2016135799A (ja) 2007-12-11 2016-04-18 損傷した創傷治癒組成物および治療

Country Status (8)

Country Link
US (1) US20100279921A1 (https=)
EP (1) EP2245158A2 (https=)
JP (3) JP2011506447A (https=)
CN (2) CN101970663A (https=)
AU (2) AU2008335718A1 (https=)
CA (1) CA2709153A1 (https=)
WO (1) WO2009075882A2 (https=)
ZA (1) ZA201004998B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102073629B1 (ko) 2005-02-03 2020-02-05 코다 테라퓨틱스 (엔지) 리미티드 항-코넥신 화합물 및 그의 용도
EP2543377A1 (en) 2006-12-11 2013-01-09 Coda Therapeutics, INC. Anticonnexin polynucleotides as impaired wound healing compositions
JP2011507859A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス, インコーポレイテッド 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用
WO2009085268A2 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions
WO2009085271A2 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions
US20110092449A1 (en) * 2007-12-21 2011-04-21 Bradford James Duft Treatment of fibrotic conditions
EP2252320A2 (en) * 2007-12-21 2010-11-24 Coda Therapeutics, Inc. Use of anti-connexin polynucleotides and peptides for the treatment of abnormal or excessive scars
US8975237B2 (en) 2007-12-21 2015-03-10 Coda Therapeutics, Inc. Treatment of fibrotic conditions
CA2710386A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Improved medical devices
DK2819682T3 (en) 2012-03-01 2017-08-21 Firststring Res Inc TOPICAL GELLS CONTAINING ALPHA-CONNEXIN C-TERMINAL (ACT) PEPTIDES
US20140031753A1 (en) * 2012-07-25 2014-01-30 Neil T. Winthrop Thoracostomy devices and methods of use
US9156896B2 (en) 2013-03-15 2015-10-13 Coda Therapeutics, Inc. Wound healing compositions and treatments
CA2940648A1 (en) * 2014-02-25 2015-09-03 Coda Therapeutics, Inc. Treatment of resistant lesions
CN107109410B (zh) 2014-08-22 2021-11-02 奥克兰联合服务有限公司 通道调节剂
US9885042B2 (en) * 2015-01-20 2018-02-06 MiRagen Therapeutics, Inc. miR-92 inhibitors and uses thereof
CA3061738A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
CN109513037B (zh) * 2018-11-14 2021-09-17 华中科技大学同济医学院附属协和医院 一种负载介孔生物玻璃的小肠粘膜下层创面敷料
WO2021119198A1 (en) * 2019-12-09 2021-06-17 Cage Bio, Inc. Topical delivery of rna interference agents using ionic liquid
CN111214694B (zh) * 2020-03-31 2022-04-22 山东大鱼生物技术有限公司 一种具有止血和加速伤口愈合功能的敷料及其制备方法
MX2023004631A (es) 2020-10-22 2023-07-20 Xequel Bio Inc Formulaciones peptidicas y usos oftalmicos de las mismas.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0539594Y2 (https=) * 1988-08-05 1993-10-07
US5166195A (en) * 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
EP2314321B1 (en) * 1999-01-27 2014-06-04 Coda Therapeutics, Inc. Formulations comprising antisense nucleotides to connexins
US7250397B2 (en) * 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
US20050119211A1 (en) * 2001-05-18 2005-06-02 Sirna Therapeutics, Inc. RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
CN1638790A (zh) * 2002-01-29 2005-07-13 Wyeth公司 用于调节连接蛋白半通道的组合物和方法
RU2438696C2 (ru) * 2004-12-21 2012-01-10 Маск Фаундейшн Фор Рисерч Дивелопмент Композиции и способы, используемые для ускорения заживления ран и регенерации тканей
KR102073629B1 (ko) * 2005-02-03 2020-02-05 코다 테라퓨틱스 (엔지) 리미티드 항-코넥신 화합물 및 그의 용도
AU2007319811A1 (en) * 2006-11-15 2008-05-22 Coda Therapeutics, Inc. Improved methods and compositions for wound healing
EP2543377A1 (en) * 2006-12-11 2013-01-09 Coda Therapeutics, INC. Anticonnexin polynucleotides as impaired wound healing compositions
WO2009075881A2 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
WO2009085271A2 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions
WO2009085268A2 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions
US20110092449A1 (en) * 2007-12-21 2011-04-21 Bradford James Duft Treatment of fibrotic conditions
EP2252690A2 (en) * 2007-12-21 2010-11-24 Coda Therapeutics, Inc. Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
CA2711635A1 (en) * 2008-01-07 2009-08-06 Coda Therapeutics, Inc. Wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP2011506447A5 (https=)
JP2011507860A5 (https=)
RU2009122370A (ru) Улучшенные способы и композиции для заживления ран
JP2011507858A5 (https=)
JP2011507861A5 (https=)
JP2025128190A5 (https=)
JP2011507855A5 (https=)
JP2010512404A5 (https=)
US8975237B2 (en) Treatment of fibrotic conditions
SA517381997B1 (ar) تركيبة لتضميد الجرح
US20110130710A1 (en) Treatment of abnormal or excessive scars
CA2730789A1 (en) Treatment of inflammatory bowel diseases with mammal beta defensins
JP2019214592A (ja) ベンダムスチンの製剤
CN102920996A (zh) 受损伤口愈合的药物组合物
CN104271149A (zh) 经皮递送装置
JP2015057430A (ja) 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用
JP2010536745A5 (https=)
Deng et al. Hydrogel-exosome systems in the treatment of refractory diabetic ulcers: mechanisms, progress, and prospects
JP6196704B2 (ja) 神経因性疾病の治療のための医薬
KR20120014251A (ko) 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법
CA2710227A1 (en) Treatment of surgical adhesions
CN101896190A (zh) 用α胸腺肽和抗细胞毒性T淋巴细胞相关抗原4(CTLA4)的抗体的组合治疗黑素瘤
AU2006206393A1 (en) Methods for treating adhesive capsulitis
JP2012524725A5 (https=)
Karri et al. Understanding the implications of pharmaceutical excipients and additives in the treatment of diabetic foot ulcers